1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2020The Kiplinger Washington Editors
When investors think of biotech stocks, visions of Amgen (AMGN) and Gilead (
Our picks should deliver solid long-term gains with less drama than the racy tech and biotech stocks strutting in the limelight.
Health scares can really spook the market, as February's coronavirus-sparked market drubbing illustrates. But we still have portfolios to manage, even if it seems like the world is ending, and that...
More Investing News »